Qiang Wang

9PUBLICATIONS
25CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2026
Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma.

|Feb 16, 2026
T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers.

Yufei Zhang, Wei Xiong, Jianfei Qian

|Apr 03, 2025
Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss.

Liuling Xiao, Rui Duan, Wendao Liu

|Jul 09, 2024
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis.

Miao Xian, Qiang Wang, Liuling Xiao

|Sep 30, 2021
ALCAM-EGFR interaction regulates myelomagenesis.

Hongmei Luo, Dan Zhang, Fangfang Wang

|Aug 19, 2021
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway.

Qiang Wang, Zhijuan Lin, Zhuo Wang

Pageof 2

Frequent Collaborators

8 joint publications

Qing Yi

3 joint publications

Miao Xian

3 joint publications

Wei Xiong

2 joint publications

Yong Lu